Mucinex
- Product NDC
- 17856-0008
- 11-digit product format
- 178560008
- Labeler code
- 17856
- Product ID
- 17856-0008_45244b74-1b9b-2f5d-e063-6394a90a1002
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICAS CORP.
- Application
- NDA021282
- Marketing category
- NDA
- Marketing start
- 2012-07-03
- Substance
- GUAIFENESIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mucinex
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 636522, 891301 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17856-0008-2 | Mucinex | 1 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 1 | | 9 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Guaifenesin | ACTIVE INGREDIENT | 495W7451VQ | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| Guaifenesin | ACTIVE MOIETY | 495W7451VQ | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | HHT01ZNK31 | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORPS] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17856-0008 | MUCINEX (GUAIFENESIN) TABLET, EXTENDED RELEASE [ATLANTIC BIOLOGICAS CORP.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240606_40c67cca-f202-4652-9507-2442d26cfd67.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 17856-0008-2 | 17856000802 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (17856-0008-2) | 2024-06-05 | 0000-00-00 | No | No | Current |